GPT Healthcare Limited (NSE:GPTHEALTH)
India
· Delayed Price · Currency is INR 150.10
-0.15 (-0.10%)
Jun 13, 2025, 3:29 PM IST
GPT Healthcare Revenue
In the fiscal year ending March 31, 2025, GPT Healthcare had annual revenue of 4.07B INR with 1.72% growth. GPT Healthcare had revenue of 1.01B in the quarter ending March 31, 2025, with 1.99% growth.
Revenue
4.07B
Revenue Growth
+1.72%
P/S Ratio
3.03
Revenue / Employee
2.16M
Employees
1,887
Market Cap
12.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.07B | 68.98M | 1.72% |
| Mar 31, 2024 | 4.00B | 391.56M | 10.85% |
| Mar 31, 2023 | 3.61B | 236.22M | 7.00% |
| Mar 31, 2022 | 3.37B | 946.62M | 39.00% |
| Mar 31, 2021 | 2.43B | 309.09M | 14.59% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
GPT Healthcare News
- 6 weeks ago - GPT Healthcare commissions 158-bed quaternary care hospital in Raipur, Chhattisgarh - Business Upturn
- 7 months ago - GPT Healthcare Q2 FY25 Results: Revenue down 2.1% YoY to Rs 108.47 crore, Net Profit falls 10.5% YoY - Business Upturn